Records containing: Keratoconjunctivitis Sicca
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-19Tolerability and Efficacy of Reinnerva/Lubristil+G vs Vismed in the Treatment of the Ocular Surface of Patients With Quali-quantitative Alteration of Lacrimal Film of Different Origins
-
CLINICAL_TRIALS study record update · 2025-12-04A Randomized Placebo-controlled, Double Blind Pilot Crossover Trial of Levocarnitine for the Treatment of Keratoconjunctivitis Sicca in Sjogren's Syndrome
-
CLINICAL_TRIALS study record update · 2025-10-20A Phase 2, Multicenter, Randomized, Open-Labeled, Artificial Tear-Controlled, 6-Week Clinical Study to Assess the Dose Regimen, Safety and Efficacy of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
-
CLINICAL_TRIALS study record update · 2025-05-06A Phase 4, Single Center, Open Label Study Evaluating the Safety of the Nasal Guide Utilized During Administration With Tyrvaya
-
CLINICAL_TRIALS study record update · 2024-09-20Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-05-14Clinical Efficacy of Smile Exercise Versus 0.1% Hyaluronic Acid Sodium Eye Drops for Dry Eye Symptoms in Patients With Dry Eye Disease: a Randomized, Controlled, Non-inferiority Trial
-
CLINICAL_TRIALS study record update · 2023-10-27Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
-
CLINICAL_TRIALS study record update · 2023-09-07Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
-
CLINICAL_TRIALS study record update · 2023-03-09Multi-Center, Randomized,Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy Study of Tavilermide Ophthalmic Solutions for the Treatment of Dry Eye
-
CLINICAL_TRIALS study record update · 2023-01-05Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
-
CLINICAL_TRIALS study record update · 2022-04-12Prevalence of Ocular Manifestations in Inflammatory Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2021-12-10A Randomized, Double-Masked, Vehicle-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution (VOS) in Subjects With Dry Eye Syndrome (DES)
-
CLINICAL_TRIALS study record update · 2021-10-19Randomized, Controlled, Crossover Study Comparing Tear Production by Nasal Neurostimulation Versus Active Control
-
CLINICAL_TRIALS study record update · 2021-05-14Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
-
CLINICAL_TRIALS study record update · 2021-01-06A Phase II, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
-
CLINICAL_TRIALS study record update · 2020-12-03A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
-
CLINICAL_TRIALS study record update · 2020-12-03A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
-
CLINICAL_TRIALS study record update · 2020-10-14Phase 2, Single-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophth Sol'n in the Environment and During Challenge in the Controlled Adverse Environment (CAE) Model for the Treatment of DES
-
CLINICAL_TRIALS study record update · 2020-05-27A 24-week Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Evaluation of the Safety and Efficacy of 0.3% and 1% Pimecrolimus Ophthalmic Suspensions Used Twice Daily in Patients With Moderate to Severe Keratoconjunctivitis Sicca
-
CLINICAL_TRIALS study record update · 2020-02-05Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca.
-
CLINICAL_TRIALS study record update · 2019-08-30A Randomized, Multi-Center, Parallel-Group, Safety and Efficacy Study of Lotemax® Gel 0.5% and Restasis 0.05% for 12 Weeks in Subjects With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease; DED)
-
CLINICAL_TRIALS study record update · 2019-08-16A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
-
CLINICAL_TRIALS study record update · 2019-08-16A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Disease
-
CLINICAL_TRIALS study record update · 2019-05-23Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
-
CLINICAL_TRIALS study record update · 2019-05-17Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease